Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IGEV Followed by ASCT in Refractory or Relapsed Hodgkin Lymphoma
NCT01333605Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Apr 2011
- Primary completion
- Apr 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ifosfamide, gemcitabine, vinorelbine, prednisone in Hodgkin lymphoma (HL), sponsored by Fudan University. Status: unknown.
02
Drugs
ifosfamidegemcitabinevinorelbineprednisone
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01333605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333605.